Skylark Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ankleshwar, Gujarat, India, established in 2005.
2005 Ankleshwar, Gujarat, India Active
Last Updated:
Access Report
About Skylark Pharmaceuticals Private Limited

Skylark Pharmaceuticals Private Limited, a active private limited company, was established on 18 July 2005 in Ankleshwar, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PTC046440. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 6 professional, Its leadership includes Kamleshkumar Gaurishankar Patel (Director), Mukesh Narbheram Chadderwala (Director), Prakashbhai Narbhaeram Chadderwala (Director). Past directors included Kapilaben Narbheram Chadderwala, Prakashbhai Narbhaeram Chadderwala. It holds no open charges and ₹10.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 7910 Gidc Ankleshwar, Ankleshwar, Gujarat, 393002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2005PTC046440

  • Registration Number

    046440

  • Incorporation Date

    18 July 2005

  • Authorized Capital

    ₹7.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 20 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 10.50 Cr
  • Revenue Growth **** -40.32%
  • Profit Growth **** -11.33%
  • Ebitda **** -218.45%
  • Net Worth -12.91%
  • Total Assets -6.84%
Company report

Skylark Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Skylark Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Skylark Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kamleshkumar Gaurishankar Patel Director 18 Jul 2005 Current
Mukesh Narbheram Chadderwala Director 18 Jul 2005 Current
Prakashbhai Narbhaeram Chadderwala Director 11 Apr 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 May 2009 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skylark Pharmaceuticals.

Skylark Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 40.32% decrease. The company also saw a substantial fall in profitability, with a 11.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.91%.

Skylark Pharmaceuticals revenue growth over time
Skylark Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -40.32%
*******
*******
*******
*******
Revenue from Operations
*******
 -43.73%
*******
*******
*******
*******
Total Assets
*******
 -6.84%
*******
*******
*******
*******
Profit or Loss
*******
 -11.33%
*******
*******
*******
*******
Net Worth
*******
 -12.91%
*******
*******
*******
*******
EBITDA
*******
 -218.45%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skylark Pharmaceuticals?

Unlock access to Skylark Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹105,000,000.00

Charges Breakdown by Lending Institutions
  • Prime Co-Operative Bank Limited : 8.00 Cr
  • Others : 2.50 Cr
Latest Charge Details
Date Lender Amount Status
29 Oct 2020 Others ₹1.00 Cr Satisfied
04 Jun 2016 Others ₹1.50 Cr Satisfied
19 Feb 2014 Prime Co-Operative Bank Limited ₹5.50 Cr Satisfied
01 Jan 2014 Prime Co-Operative Bank Limited ₹2.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Skylark Pharmaceuticals?

Skylark Pharmaceuticals has a workforce of 6 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skylark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skylark Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skylark Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 29 Oct 2020 via Charge ID 100387720 with Others was fully satisfied on 25 Nov 2024. was completed.

  • Charges

    A charge registered on 04 Jun 2016 via Charge ID 100034244 with Others was fully satisfied on 25 Nov 2024. was recorded as a recent event.

  • Charges

    A charge registered on 19 Feb 2014 via Charge ID 10480639 with Prime Co-Operative Bank Limited was fully satisfied on 25 Nov 2024. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 01 Jan 2014 via Charge ID 10473923 with Prime Co-Operative Bank Limited was fully satisfied on 25 Nov 2024. was documented.

  • Annual General Meeting

    Progress on Skylark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Skylark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skylark Pharmaceuticals Private Limited?

The CIN of Skylark Pharmaceuticals Private Limited is U24230GJ2005PTC046440.

Where is Skylark Pharmaceuticals Private Limited headquartered?

Skylark Pharmaceuticals Private Limited is headquartered at Plot No. 7910 Gidc Ankleshwar, Ankleshwar, Gujarat, 393002.

When was Skylark Pharmaceuticals Private Limited incorporated?

Skylark Pharmaceuticals Private Limited was incorporated on 18 July 2005.

Who are the current directors of Skylark Pharmaceuticals Private Limited?

The current directors of Skylark Pharmaceuticals Private Limited are

What is the primary industry of Skylark Pharmaceuticals Private Limited?

The primary industry of Skylark Pharmaceuticals Private Limited is Manufacturing.

Is Skylark Pharmaceuticals Private Limited a listed company?

Skylark Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Skylark Pharmaceuticals Private Limited?

The authorized capital of Skylark Pharmaceuticals Private Limited is ₹7.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Skylark Pharmaceuticals Private Limited?

The compliance status of Skylark Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available